Shilpa Medicare rises on receiving USFDA compliance letter for Karnataka plant

The stock surged 9% to Rs 453 on receiveing compliance letter from USFDA for API manufacturing sites in Karnataka

Image via shutterstock.com
Image via shutterstock.com
SI Reporter Mumbai
Last Updated : Feb 11 2016 | 10:00 AM IST
Shilpa Medicare has surged 9% to Rs 453 on the National Stock Exchange (NSE) in otherwise weak market after the company announced that it has received compliance letter from United State Food and Drug Administration (USFDA) for API manufacturing sites in Karnataka.

“The company have received compliance letter from USFDA for both API manufacturing sites located at Raichur, Karnataka, India (Unit-1: Deosugur Industrial Area, Deosugur, Raichur, Karnataka, India and Unit-2: Raichur Industrial Growth Centre, Chicksugur, Raichur, Karnataka, India),” Shilpa Medicare said in a BSE filing.

The stock hit a high of Rs 476 and has seen an over two-fold jump in trading volumes. A combined 198,456 shares changed hands on the counter on the BSE and NSE till 09:45 am.
 

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 11 2016 | 9:50 AM IST

Next Story